Genetics of IgA Nephrology: Risks, Mechanisms, and Therapeutic Targets

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2024 Apr 10

PMID 38600219

Authors

Shu Qu

Xu-Jie Zhou

Hong Zhang

Affiliations

Soon will be listed here.

Abstract

IgA nephropathy (IgAN) is a genetically complex multifactorial trait. Over the past decade, population-based genome-wide association studies (GWAS) have identified more than 30 IgAN risk loci, providing novel perspectives on both the epidemiology of the disease and its underlying molecular mechanisms. In addition, the association between IgAN and galactose-deficient IgA1 (Gd-IgA1) presented another avenue for genetic exploration due to the heritability of the elevated serum Gd-IgA1 levels. These endeavors also yielded and enabled refinement of polygenic risk scores, which may help identify specific groups of individuals at significantly increased risks, leading to stratifications of medical treatments. In this review, we aim to explore the existing evidence for genetic causation in IgAN. We summarize the state of genetic research in IgAN and how it has led to the reformulation of the new pathogenesis model and novel therapeutic targets.

Citing Articles

A practical guide for nephrologist peer reviewers: understanding and appraising Mendelian randomization studies.

Qing J, Li Y, Soliman K, Cheungpasitporn W Ren Fail. 2025; 47(1):2445763.

PMID: 39806780 PMC: 11734392. DOI: 10.1080/0886022X.2024.2445763.

References

Lai K, Tang S, Schena F, Novak J, Tomino Y, Fogo A . IgA nephropathy. Nat Rev Dis Primers. 2016; 2:16001. DOI: 10.1038/nrdp.2016.1. View

Li M, Yu X . Genetic Determinants of IgA Nephropathy: Eastern Perspective. Semin Nephrol. 2018; 38(5):455-460. DOI: 10.1016/j.semnephrol.2018.05.015. View

Kiryluk K, Sanchez-Rodriguez E, Zhou X, Zanoni F, Liu L, Mladkova N . Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet. 2023; 55(7):1091-1105. PMC: 11824687. DOI: 10.1038/s41588-023-01422-x. View

Neugut Y, Kiryluk K . Genetic Determinants of IgA Nephropathy: Western Perspective. Semin Nephrol. 2018; 38(5):443-454. DOI: 10.1016/j.semnephrol.2018.05.014. View

Zhang Z, Zhang Y, Zhang H . IgA Nephropathy: A Chinese Perspective. Glomerular Dis. 2023; 2(1):30-41. PMC: 9677733. DOI: 10.1159/000520039. View

Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F . Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet. 2012; 8(6):e1002765. PMC: 3380840. DOI: 10.1371/journal.pgen.1002765. View

Cosimi A, Fuller T, Rublin R, Colvin R . IGA nephropathy in HLA-identical siblings. Transplantation. 1978; 26(6):430-3. DOI: 10.1097/00007890-197812000-00014. View

Kiryluk K, Julian B, Wyatt R, Scolari F, Zhang H, Novak J . Genetic studies of IgA nephropathy: past, present, and future. Pediatr Nephrol. 2010; 25(11):2257-68. PMC: 2937145. DOI: 10.1007/s00467-010-1500-7. View

Schena F, Cerullo G, Rossini M, Lanzilotta S, DAltri C, Manno C . Increased risk of end-stage renal disease in familial IgA nephropathy. J Am Soc Nephrol. 2002; 13(2):453-460. DOI: 10.1681/ASN.V132453. View

10.

Hoy W, Hughson M, Smith S, Megill D . Mesangial proliferative glomerulonephritis in southwestern American Indians. Am J Kidney Dis. 1993; 21(5):486-96. DOI: 10.1016/s0272-6386(12)80394-5. View

11.

Shi M, Yu S, Ouyang Y, Jin Y, Chen Z, Wei W . Increased Lifetime Risk of ESRD in Familial IgA Nephropathy. Kidney Int Rep. 2021; 6(1):91-100. PMC: 7783566. DOI: 10.1016/j.ekir.2020.10.015. View

12.

Shimozato S, Hiki Y, Odani H, Takahashi K, Yamamoto K, Sugiyama S . Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy. Nephrol Dial Transplant. 2008; 23(6):1931-9. DOI: 10.1093/ndt/gfm913. View

13.

Kiryluk K, Moldoveanu Z, Sanders J, Eison T, Suzuki H, Julian B . Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int. 2011; 80(1):79-87. PMC: 3641561. DOI: 10.1038/ki.2011.16. View

14.

Gharavi A, Moldoveanu Z, Wyatt R, Barker C, Woodford S, Lifton R . Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol. 2008; 19(5):1008-14. PMC: 2386728. DOI: 10.1681/ASN.2007091052. View

15.

Hastings M, Moldoveanu Z, Julian B, Novak J, Sanders J, McGlothan K . Galactose-deficient IgA1 in African Americans with IgA nephropathy: serum levels and heritability. Clin J Am Soc Nephrol. 2010; 5(11):2069-74. PMC: 3001782. DOI: 10.2215/CJN.03270410. View

16.

Lin X, Ding J, Zhu L, Shi S, Jiang L, Zhao M . Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy. Nephrol Dial Transplant. 2009; 24(11):3372-5. DOI: 10.1093/ndt/gfp294. View

17.

Lomax-Browne H, Visconti A, Pusey C, Cook H, Spector T, Pickering M . IgA1 Glycosylation Is Heritable in Healthy Twins. J Am Soc Nephrol. 2016; 28(1):64-68. PMC: 5198287. DOI: 10.1681/ASN.2016020184. View

18.

Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M . Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet. 2014; 46(11):1187-96. PMC: 4213311. DOI: 10.1038/ng.3118. View

19.

Sanchez-Rodriguez E, Southard C, Kiryluk K . GWAS-Based Discoveries in IgA Nephropathy, Membranous Nephropathy, and Steroid-Sensitive Nephrotic Syndrome. Clin J Am Soc Nephrol. 2020; 16(3):458-466. PMC: 8011010. DOI: 10.2215/CJN.14031119. View

20.

Buren M, Yamashita M, Suzuki Y, Tomino Y, Emancipator S . Altered expression of lymphocyte homing chemokines in the pathogenesis of IgA nephropathy. Contrib Nephrol. 2007; 157:50-5. DOI: 10.1159/000102304. View